The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Apoptotic activity in patient serum while on an acai juice product in the setting of a slowly rising PSA.
Elizabeth Kessler
No relevant relationships to disclose
Lih-Jen Su
No relevant relationships to disclose
Xian Lu
No relevant relationships to disclose
Diana Morales
No relevant relationships to disclose
Nicole Chronister
No relevant relationships to disclose
Mary Anduha
No relevant relationships to disclose
Michael Wacker
No relevant relationships to disclose
Xiaoping Yang
No relevant relationships to disclose
Thomas W. Flaig
Employment or Leadership Position - Aurora Oncology (Other)
Consultant or Advisory Role - GTx; Sanofi
Honoraria - Amgen
Research Funding - Amgen; Bayer/Onyx; BN ImmunoTherapeutics; Cougar Biotechnology; Dendreon; Genentech; GlaxoSmithKline; GTx; Janssen Oncology; Medivation; Novartis; Pfizer; Sanofi ; Veridex; Zymogenetics
Other Remuneration - Aurora Oncology (Intellectual Property Interests)
L. Michael Glode
No relevant relationships to disclose
Elaine Tat Lam
No relevant relationships to disclose